Pfizer and Moderna decline request by J&J to study the risks of blood clots – WSJ

(Reuters) – Johnson & Johnson had reached out to rival COVID-19 vaccine makers to join in an effort to study the risks of blood clots, but Pfizer Inc and Moderna declined, the Wall Street Journal reported on Friday.

Only AstraZeneca, which had been buffeted by similar blood-clotting concerns for weeks, agreed, the report said, citing people familiar with the matter. (https://on.wsj.com/2Q7E4Ho)

(Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)

Discover more from The Dispatch

Subscribe now to keep reading and get access to the full archive.

Continue reading

Verified by MonsterInsights